AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Revenue

In the year 2024, AbCellera Biologics had annual revenue of $28.83M, down -24.17%. AbCellera Biologics had revenue of $5.05M in the quarter ending December 31, 2024, a decrease of -44.98%.

• Revenue (ttm): $28.83M
• Revenue Growth: -24.17%
• P/S Ratio: 26.54
• Revenue / Employee: $48,378
• Employees: 596
• Market Cap: 773.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.